Sai Life Sciences opens SSRL, a dedicated research facility for Schrödinger, at its Hyderabad R&D Campus
April 20, 2023 10:29 AM EDTUpdated 03:05 PM
R&D

Up­dat­ed: In­di­an CD­MO opens 'ded­i­cat­ed' R&D site for Schrödinger as part of five-year agree­ment

Paul Schloesser

Associate Editor

A CRO and CD­MO in In­dia has opened some labs in part­ner­ship with a drug dis­cov­ery biotech and com­pu­ta­tion­al plat­form mak­er.

Sai Life Sci­ences …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times